Thymosin Alpha-1
Approvedaka Tα1, Zadaxin
Thymic immune-modulating peptide. Approved across much of the world, just not the US.
Mechanism
A natural thymic peptide that ramps up T-cell and innate immune activity. It's used abroad as an immune modulator and even a vaccine adjuvant, with a real clinical track record behind it.
Regulatory & Safety Status
Approved and sold in plenty of countries (Zadaxin) for hepatitis and immune support. Not FDA-approved in the US, where it sits in the research-chemical bucket.
Research
Efficacy and safety of thymosin α1 combined with chemotherapy for gastric cancer: a systematic review and meta-analysis of randomized controlled trials
Clinical Applications and Evidence Landscape of Thymosin Alpha 1 as an Immunomodulatory Adjunct in Cancer Care: A Scoping Review
Thymosin-ɑ1 for people with chronic hepatitis B
A prospective clinical study on the effectiveness of Phellinus igniarius decoction in treating immune dysfunction in colorectal cancer patients following chemfotherapy
Latest thymosin alpha-1 research